These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15734198)

  • 1. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.
    Krause M; Schütze C; Petersen C; Pimentel N; Hessel F; Harstrick A; Baumann M
    Radiother Oncol; 2005 Feb; 74(2):109-15. PubMed ID: 15734198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.
    Krause M; Ostermann G; Petersen C; Yaromina A; Hessel F; Harstrick A; van der Kogel AJ; Thames HD; Baumann M
    Radiother Oncol; 2005 Aug; 76(2):162-7. PubMed ID: 16024114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma.
    Krause M; Hessel F; Zips D; Hilberg F; Baumann M
    Radiother Oncol; 2004 Jul; 72(1):95-101. PubMed ID: 15236881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?
    Krause M; Prager J; Zhou X; Yaromina A; Dörfler A; Eicheler W; Baumann M
    Radiother Oncol; 2007 Jun; 83(3):316-25. PubMed ID: 17531334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse.
    Baumann M; Krause M; Zips D; Eicheler W; Dörfler A; Ahrens J; Petersen C; Brüchner K; Hilberg F
    Int J Radiat Biol; 2003 Jul; 79(7):547-59. PubMed ID: 14530164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
    Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
    Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cetuximab and fractionated irradiation on tumour micro-environment.
    Santiago A; Eicheler W; Bussink J; Rijken P; Yaromina A; Beuthien-Baumann B; van der Kogel AJ; Baumann M; Krause M
    Radiother Oncol; 2010 Nov; 97(2):322-9. PubMed ID: 20667608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results.
    Zips D; Krause M; Yaromina A; Dörfler A; Eicheler W; Schütze C; Gurtner K; Baumann M
    J Pharm Pharmacol; 2008 Aug; 60(8):1019-28. PubMed ID: 18644194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
    Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
    Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
    Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
    Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
    Schreiber A; Krause M; Zips D; Dörfler A; Richter K; Vettermann S; Petersen C; Beuthien-Baumann B; Thümmler D; Baumann M
    Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy.
    Nakata E; Hunter N; Mason K; Fan Z; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1163-73. PubMed ID: 15234052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
    Milas L; Mason K; Hunter N; Petersen S; Yamakawa M; Ang K; Mendelsohn J; Fan Z
    Clin Cancer Res; 2000 Feb; 6(2):701-8. PubMed ID: 10690556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression.
    Gurtner K; Deuse Y; Bütof R; Schaal K; Eicheler W; Oertel R; Grenman R; Thames H; Yaromina A; Baumann M; Krause M
    Radiother Oncol; 2011 Jun; 99(3):323-30. PubMed ID: 21665304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
    Milas L; Fang FM; Mason KA; Valdecanas D; Hunter N; Koto M; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):568-72. PubMed ID: 17236972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
    Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
    Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.
    Toulany M; Dittmann K; Baumann M; Rodemann HP
    Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
    Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M
    Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude mice.
    Eicheler W; Krause M; Hessel F; Zips D; Baumann M
    Radiother Oncol; 2005 Aug; 76(2):151-6. PubMed ID: 16026875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
    Schütze C; Bergmann R; Yaromina A; Hessel F; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
    Radiother Oncol; 2007 Jun; 83(3):311-5. PubMed ID: 17502117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.